Avian medicine in the United States and abroad tends to be more focused on crisis and intervention than on preventive care and wellness. Therefore, in this article I discuss some of the basic considerations of emergency medical care in pet birds.
Adequate analgesic treatment of both acute perioperative pain and chronic pain in dogs is recognized by the veterinary profession and the general public as imperative to appropriate and humane medical care.
In this double-blind, prospective, and randomized clinical trial from France, 60 dogs undergoing orthopedic surgery were treated with either preoperative meloxicam (0.2 mg/kg intravenously) or intraoperative ketoprofen (2 mg/kg intravenously) and assessed for pain for up to 24 hours after surgery.
Because cats are relatively quiet creatures, that is, they don't bark, whine, and announce themselves, their analgesic needs are often ignored or forgotten. Evaluating pain in cats is challenging and requires intense and prolonged observation, intuition, interaction with the animal, and knowledge of the various feline behaviors that may signal pain.
Recent publications, ongoing prospective studies, and better knowledge of the available therapeutic options should provide the necessary framework for appropriate pain management in cancer-bearing pets.
The interview stage is where we separate the women from the girls, the marrow from the bone, the competent from the inept. This is where we decide who is to receive our largesse and enjoy the not-so-great employment opportunity we offer so magnanimously.
A founding member of the American College of Veterinary Anesthesiologists, Dr. Short is a professor emeritus of anesthesiology and pain management at Cornell University. Throughout his veterinary career, he has strived to boost the recognition and control of pain in animals.
In this prospective clinical study, the effect of perioperative oral carprofen on limb function and pain after cranial cruciate ligament surgery was evaluated in 20 dogs treated at a university teaching hospital.
Practitioners might soon rely on a new procedure to alleviate severe chronic pain resulting from cancer, osteoarthritis or surgery. Resiniferatoxin (RTX), first isolated in the 1970s, has been administered during a series of clinical studies to kill specific nerve cells while leaving others untouched.